U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754617) titled 'Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis: an RCT' on Aug... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07753902) titled 'Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting Conditio... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756281) titled 'First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Ca... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755566) titled 'Effect of Papilozumib Oral on Vaginal and Intestinal Microbiota in HPV-Positive Women' on A... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755293) titled 'Self-Efficacy, Surgical Fear and Psychological Well-Being in Abdominal Surgery' on Aug. 05.... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756151) titled 'THE EFFECT OF BITTER ORANGE (CITRUS AURANTIUM) OIL AROMATHERAPY ON SLEEP QUALITY AND FATIGU... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756593) titled 'Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Re... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755358) titled 'Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance and Passin... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More